Journal of the Pancreas is believed to be the most authenticated peer-reviewed journals on Islet cell carcinoma. The journal is using Editorial Manager System for quality in peer review process. Journal of the Pancreas Editorial and reviewerâs team ensures the quality and rapid editorial, review processing with publishing time of just 21 days from the day of submission of manuscript.
Islet cell carcinoma is an uncommon cancer of the endocrine pancreas. It accounts for approximately 1.3% of pancreatic cancer. It is also known as or nesidioblastoma. Pancreatic islet cell tumors can be benign or malignant. Islet cells produce many different hormones; most tumors release only one hormone that leads to specific symptoms. There are different types of islet cell tumor such as: Gastrinomas (Zollinger-Ellison syndrome), Glucagonomas, Insulinomas. Islet cell tumors are treatable even after they have metastasized. Symptoms include sweating, Headache, Hunger, anxiety, Double or blurry vision, pounding heartbeat, Diarrhea, Ulcers in the stomach and small bowel, Vomiting blood etc.
OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 700+ peer-reviewed journals and has organized over 3000+ International Scientific Conferences all over the world. OMICS International journals have over 15 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50,000+ editorial board members and the rapid, quality and quick review processing.
Last date updated on June, 2014